New Products Posted to GenomeWeb | GenomeWeb

Fluidigm's Polaris

Fluidigm said this week that it will provide attendees of the Advances in Genome Biology and Technology meeting a first look at the firm's new Polaris single-cell research system. Polaris integrates cell selection, isolation, dose, culture, and molecular preparation into a single workflow. According to the firm, it will enable researchers to directly correlate gene expression with environmental conditions and phenotypic information. Fluidigm plans to begin shipping the new system mid-year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.